Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - sulindac - oral tablet - 200mg

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - sulindac -

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

bryant ranch prepack - sulindac (unii: 184sns8vuh) (sulindac - unii:184sns8vuh) - carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. osteoarthritis 2. rheumatoid arthritis** 3. ankylosing spondylitis 4. acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) 5. acute gouty arthritis **the safety and effectiveness of sulindac tablets usp have not been established in rheumatoid arthritis patients who are designated in the american rheumatism association classification as functional class iv (incapacitated, largely or wholly bedridden, or confined to wheelchair, little or no self-care). sulindac is contraindicated in patients with known hypersensitivity to sulindac or the excipients (see description ). sulindac should

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

a-s medication solutions - sulindac (unii: 184sns8vuh) (sulindac - unii:184sns8vuh) - carefully consider the potential benefits and risks of sulindac and other treatment options before deciding to use sulindac. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). sulindac is indicated for acute or long-term use in the relief of signs and symptoms of the following: 1. osteoarthritis 2. rheumatoid arthritis** 3. ankylosing spondylitis 4. acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) 5. acute gouty arthritis sulindac is contraindicated in patients with known hypersensitivity to sulindac or the excipients (see description ). sulindac should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nsaids. severe, rarely fatal, anaphylactic/anaphylactoid reactions to nsaids have been reported in such patients (see warnings – anaphylactic/anaphylactoid reactions, and precautions – preexisting asthma ). sulindac is contraindicated

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

direct rx - sulindac (unii: 184sns8vuh) (sulindac - unii:184sns8vuh) - sulindac 200 mg - carefully consider the potential benefits and risks of sulindac tablets and other treatment options before deciding to use sulindac tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). sulindac tablets are indicated for acute or long-term use in the relief of signs and symptoms of the following: osteoarthritis rheumatoid arthritis1 ankylosing spondylitis acute painful shoulder (acute subacromial bursitis/supraspinatus tendinitis) acute gouty arthritis 1 the safety and effectiveness of sulindac tablets have not been established in rheumatoid arthritis patients who are designated in the american rheumatism association classification as functional class iv (incapacitated, largely or wholly bedridden, or confined to wheelchair; little or no self-care). sulindac tablets are contraindicated in patients with known hypersensitivity to sulindac or the excipients (see description). sulindac tablets should not be give

Канада - Енглески - Health Canada

pro doc limitee - sulindac - tablet - 150mg - sulindac 150mg - other nonsteroidal antiimflammatory agents

Канада - Енглески - Health Canada

pro doc limitee - sulindac - tablet - 200mg - sulindac 200mg - other nonsteroidal antiimflammatory agents

Нови Зеланд - Енглески - Medsafe (Medicines Safety Authority)

viatris limited - sulindac 200mg; sulindac 200mg - tablet - 200 mg - active: sulindac 200mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc quinoline yellow sodium starch glycolate active: sulindac 200mg excipient: lactose monohydrate magnesium stearate microcrystalline cellulose povidone purified talc quinoline yellow sodium starch glycolate - aclin is indicated for acute or long-term use in the treatment of the following: · osteoarthritis · rheumatoid arthritis · ankylosing spondylitis · periarticular diseases such as acute painful shoulder (acute subacromial bursitis/supraspinatus tendonitis) and tenosynovitis · acute gouty arthritis · painful low back syndrome (low back pain, commonly referred to as lumbago).

Велика Британија - Енглески - MHRA (Medicines & Healthcare Products Regulatory Agency)

organon pharma (uk) ltd - sulindac - oral tablet - 100mg

Малта - Енглески - Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - sulindac - tablet - sulindac 200 mg - antiinflammatory and antirheumatic products